Hepatic hemangioma
Treatment in China

Disease Introduction

Hepatic hemangioma is the most common benign tumor of the liver. It is essentially a vascular malformation rather than a true tumor. Most are asymptomatic and grow slowly. Small to medium-sized, asymptomatic cases are mainly monitored by regular ultrasound. Surgery, interventional embolization, or ablation therapy are only considered when symptoms are obvious, the tumor grows rapidly, the size is large, or the diagnosis is uncertain.

Cutting-edge high-precision diagnostic and treatment technologies

1. Strict follow-up strategy : Asymptomatic hemangiomas located in the liver and slow-growing hemangiomas are not recommended for active intervention; regular ultrasound follow-up is sufficient.
2. Size threshold stratification : The Chinese Medical Association's popular science points out that treatment should only be considered for cases where the left liver is larger than 8 cm, the right liver is larger than 10 cm, or the liver increases in size by more than 1 to 2 cm in one year and has compressive symptoms;
3. Preoperative embolization and ablation : For large aneurysms, transarterial embolization combined with laparoscopic or ultrasound-guided thermal ablation is used to reduce intraoperative bleeding;
4. Radiofrequency ablation is strictly limited to small size : Radiofrequency ablation is effective for hemangiomas smaller than 5 cm, located in the liver parenchyma, and with a safe path. Hemangiomas larger than 5 cm are prone to complications and are not recommended.
5. Surgical resection is the most definitive treatment : partial hepatectomy and wedge resection of the liver are currently the most definitive treatment methods, with two approaches: open and laparoscopic.
6. Peking Union Medical College Hospital's four indications for treatment: obvious symptoms, complications, unclear diagnosis that cannot rule out liver cancer, and special location adjacent to important blood vessels.